Skip to content
Trial Eligibility
Menu

Rectus Sheath Block in Cardiac Surgery

NCT05833048

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cardiac Disease
  • Postoperative Pain

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 85 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Icahn School of Medicine at Mount Sinai
Last updated on ClinicalTrials.gov
July 31, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Mount Sinai Morningside Hospital Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.